Brief communication: sirolimus-associated pneumonitis: 24 cases in renal transplant recipients.
about
Systemic and nonrenal adverse effects occurring in renal transplant patients treated with mTOR inhibitorsProfiling sirolimus-induced inflammatory syndrome: a prospective tricentric observational studyA phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer.Sirolimus in pediatric renal transplantation.Phase III trial of everolimus in metastatic renal cell carcinoma: subgroup analysis of Japanese patients from RECORD-1.Incidence and risk of treatment-related mortality with mTOR inhibitors everolimus and temsirolimus in cancer patients: a meta-analysisRapamycin Regulates Bleomycin-Induced Lung Damage in SP-C-Deficient MiceSirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantationHistological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens.Sirolimus associated pneumonitis after nonmyeloablative peripheral blood stem cell transplant for sickle cell disease.Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelinesEmerging drugs in lung transplantation.Sirolimus-induced pneumonitis following liver transplantation.Risk factors for rejection and infection in pediatric liver transplantationCT patterns of organizing pneumonia in patients treated with VEGF/mTOR inhibitors for metastatic renal cell cancer: an observational studyNoninfectious pneumonitis after everolimus therapy for advanced renal cell carcinoma.Indications, tolerance and complications of a sirolimus and calcineurin inhibitor immunosuppression regimen: intermediate experience in pediatric heart transplantation recipients.An evaluation of sirolimus in renal transplantation.Drug-induced interstitial lung disease in molecular targeted therapies: high-resolution CT findings.Adverse events associated with mTOR inhibitors.mTOR inhibitors and renal allograft: Yin and Yang.Interstitial Lung Disease Associated with mTOR Inhibitors in Solid Organ Transplant Recipients: Results from a Large Phase III Clinical Trial Program of Everolimus and Review of the Literature.mTOR inhibitor-induced interstitial lung disease in cancer patients: Comprehensive review and a practical management algorithm.Safety of mTOR inhibitors in adult solid organ transplantation.mTOR inhibitors in pancreas transplant: adverse effects and drug-drug interactions.Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation.Successful treatment of Bronchiolitis obliterans with organizing pneumonia in dialysis patient.Bronchiolitis obliterans organizing pneumonia (BOOP) after renal transplantation.An unusual pulmonary complication of cytomegalovirus infection in a renal transplant recipient.Pulmonary alveolar proteinosis: a rare pulmonary toxicity of sirolimus.The use of everolimus in renal-transplant patientsSirolimus-associated acute interstitial nephritis in a renal allograft.Fatal diffuse alveolar hemorrhage associated with sirolimus after allogeneic hematopoietic cell transplantation.Multicentric outcome analysis of sirolimus-based immunosuppression in 252 liver transplant recipients.Everolimus-induced pneumonitis after drug-eluting stent implantation: a case report.Calcineurin inhibitor-free GVHD prophylaxis with sirolimus, mycophenolate mofetil and ATG in Allo-SCT for leukemia patients with high relapse risk: an observational cohort study.Alemtuzumab and sirolimus in renal transplantation: six-year results of a single-arm prospective pilot study.In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets.Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial.Interstitial pneumonitis is a frequent complication in liver transplant recipients treated with sirolimus.
P2860
Q26823023-76A23BD8-7BFE-4834-A598-C6B9F49AA92DQ28484885-195E779F-69C8-4932-B08B-F5A74CF8CD28Q33383818-AC5555F0-90EB-42A2-8883-7C1C82537B2DQ33397668-715F76E2-F298-4581-857B-530C898C50C2Q34452127-668691AB-3CD0-41C6-8C17-904EC470EFF4Q34778631-5C82E0DF-7786-4D74-A313-C60085F67B39Q35029260-BB1149F9-A75E-44D3-9EE3-99B45702E397Q35184589-61785355-55A7-46F0-8B6F-5D98B04F9D06Q35935114-1FD038FB-FFFF-4200-85EC-5862F5DE64D6Q36517807-BBC6DF25-E860-41C6-B142-50F80279ADAAQ36724093-34B31F1A-5803-4E70-9F3F-85D8F3EC9EF3Q36758582-D1C12346-380A-44B3-9695-0D908F33BB9EQ36835665-004382DD-0543-43A5-BEA1-AEF03D29FF2BQ37045877-E31F1F61-84CA-493C-A439-0E993881B367Q37695529-BABA3315-6A13-4193-8D98-A787AB6D2A80Q37701147-1CDD20A5-E602-4037-9F52-B1716C9365A6Q37705580-6D0DAADA-95EE-49BA-BD93-31D001832C22Q38038696-6A95F4C7-4226-4CC6-AEC5-34C4308FCE8EQ38058679-03411E28-976C-49CB-A008-3DB652B3A270Q38068519-0879D598-632E-4FC7-9083-B41B0453EB74Q38209973-A29BC946-0AD9-46BA-9708-5AA250A8EA46Q38314899-792053F7-E195-4116-963F-1D95E50AEF45Q38603164-F69E09E0-920F-4AB3-A74C-0244D36A0CF3Q38669190-0A931BDA-9487-474D-9EE2-833ED2F5EA2AQ38962103-DA7316D6-58FF-410A-837C-3C470496780CQ39879207-27755727-4C7C-4B19-965C-9211A93C9B0EQ40266517-0B55533B-163C-47F2-9ED9-7B0D0BFD4C46Q40288577-8057A169-B419-418F-A8BE-8005E5D9FD4FQ40321059-A5053AE9-4A9F-415A-A672-145489AC94DDQ40458154-0112B3F7-B465-4B07-B0A5-1364D7B2C5D2Q41859603-E168A429-5990-42DD-99BE-58D11783A4CBQ43225241-5FA29745-0B6C-47A2-A9D1-88EE850F8AB0Q43228485-59B99107-7DCE-4F5D-AE14-5C793ECD05D3Q43274533-5B4979F9-72F9-4C7E-BE44-15DCD4997C3EQ44057713-CCB282BB-3CE8-4CC0-BC84-29BCC680530CQ46244557-46200269-C71F-425B-B30C-2911FDF5A3FFQ51749477-D81BB752-252D-4CA8-B9C9-CBF1A6A235E8Q52314292-0BF5E001-F5ED-4088-8610-CFC89B947F70Q52650139-17BECD06-B11C-4BD0-9FB7-D742F0E92076Q53391243-C51BA392-F800-4E4F-AE46-230857EDD9CE
P2860
Brief communication: sirolimus-associated pneumonitis: 24 cases in renal transplant recipients.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Brief communication: sirolimus ...... n renal transplant recipients.
@en
type
label
Brief communication: sirolimus ...... n renal transplant recipients.
@en
prefLabel
Brief communication: sirolimus ...... n renal transplant recipients.
@en
P2093
P1476
Brief communication: sirolimus ...... in renal transplant recipients
@en
P2093
Dominique Israël-Biet
Emmanuel Morelon
Henri Kreis
Laure Champion
Marc Stern
Marie-Noëlle Peraldi
P304
P356
10.7326/0003-4819-144-7-200604040-00009
P407
P577
2006-04-01T00:00:00Z